期刊文献+

丙酮醛抗肿瘤机制的研究进展 被引量:4

Advance on the Anti-tumor Mechanism of Methylglyoxal
原文传递
导出
摘要 丙酮醛作为正常的生理代谢产物,可来源于多条代谢通路,最主要的来源是糖酵解途径,丙酮醛分解主要是在乙二醛酶系统的作用下最终转化为D-乳酸。丙酮醛具有高度的活性和细胞毒性,它在多种类型的肿瘤组织中含量较低。丙酮醛能够抑制恶性肿瘤细胞的增殖、诱导其凋亡、抑制肿瘤的转移,并能通过增强机体的免疫力以及提高对现有抗肿瘤药物的敏感性等作用更进一步地发挥抗肿瘤效应。深入研究其抗肿瘤机制能够为临床试验提供依据、使其成为有潜力的新型抗肿瘤药,该文就丙酮醛可能的作用机制予以综述。 As a normal physiological metabolites, methylglyoxal(MG) is formed from various metabolic routes, among them glycolytic pathway provides the most important source. MG is mainly catalyzed by glyoxalasesystem, it converts to D-lactate finally. MG is highly reactive and it processes cell toxicity. MG is lower in many types of cancers. The anticancer effect of MG is due to its anti-proliferative properties, the abilities of inducing apoptosis and inhibiting tumor metastasis, it can also enhance immune system and increase sensitivity to antitumor agents. Further investigation of the mechanisms will provide evidences for next stage clinical research and make this compound to be a potential therapeutic agent, the aim of this review is to summarize the mechanisms of MG′s antitumor effect.
出处 《中国细胞生物学学报》 CAS CSCD 2016年第4期449-454,共6页 Chinese Journal of Cell Biology
基金 国家自然科学基金(批准号:81170257)资助的课题~~
关键词 丙酮醛 抗肿瘤 机制 methylglyoxal anti-tumor mechanism
  • 相关文献

参考文献48

  • 1Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med 1993; 14(4): 287-371.
  • 2Lu J, Randell E, Han Y, Adeli K, Krahn J, Meng QH. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem 2011; 44(4): 307-11.
  • 3French FA, Freedlander BL. Carcinostatic action of poly- carbonyl compounds and their derivatives. I. 3-Ethoxy-2- ketobutyraldehyde and related compounds. Cancer Res 1958; 18(2): 172-5.
  • 4Talukdar D, Ray S, Ray M, Das S. A brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients. Drug Metabol Drug Interact 2008; 23(1/2): 175-210.
  • 5Allaman I, Belanger M, Magistretti PJ. Methylglyoxal, the dark side ofglycolysis. Front Neurosei 2015; 9: 23.
  • 6Richard JP. Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans 1993; 21(2): 549-53.
  • 7Thornalley PJ. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 1996; 27(4): 565-73.
  • 8Pompliano DL, Peyman A, Knowles JR. Stabilization of a reaction intermediate as a catalytic device: Definition of the functional role of the flexible loop in triosephosphate isomerase. Bioehemistry 1990; 29(13): 3186-94.
  • 9Ray S, Ray M. Isolation of methylglyoxal synthase from goat liver. J Biol Chem 1981; 256(12): 6230-3.
  • 10Reichard GA Jr, Skutches CL, Hoeldtke RD, Owen OE. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 1986; 35(6): 668-74.

同被引文献32

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部